Pancreaticoduodenectomy – outcomes from an Australian institution

Abstract

EUS and laparoscopy are useful modalities in the preoperative investigation and staging of patients being considered for PD. PD is a safe procedure with acceptable complication rates when carried out in a specialist unit experienced in this operation.

Pancreatic resection in patients with synchronous extra‐pancreatic malignancy: outcomes and complications

“…A larger cohort of patients will be required to objectively investigate overall survival in patients with synchronous pancreatic and extra‐pancreatic tumours. The median operating time of 405 min in our study is comparable to that of published reports (330–426 min) . The patients had a median LOS in intensive care unit of 3 days and a median hospital LOS of 11 days, which is shorter than a general cohort of patients with similar demographics (median LOS of 22 days) .…”

“…In the present study, the morbidity of patients with dual primary malignancies (pancreatic and other primary) did not differ significantly from that of a general cohort of pancreatic cancer patients who have undergone tumour resection . However, survival thus far is seemingly superior over the given follow‐up period .…”

Long‐term changes in body composition after pancreaticoduodenectomy

“…This reduces the bias of those values and at least indicates that patients are able to regain the protein and active tissue deficits associated with major surgery. Further, the morbidity and survival of these patients is within the bounds of recent publications 34,35 …”

Therapeutic Management of Hemorrhage from Visceral Artery Pseudoaneurysms after Pancreatic Surgery

“…[3][4][5][6] Hemorrhage after pancreatic surgery is a less common but serious complication with an incidence of 1.5% to 15%. [7][8][9] Postoperative hemorrhage may result from insufficient intraoperative hemostasis, peptic ulcer, marginal ulcer, anastomotic dehiscence, or pseudoaneurysm rupture.…”